G Wu, CJ Meininger - BioFactors, 2009 - interscience.wiley.com Obesity and type-II diabetes are growing major health issues worldwide. They are
the leading risk factors for vascular insulin resistance, which plays an
important role in the pathogenesis of cardiovascular disease, the leading ... Cited by 9 - Related articles - All 2 versions
- ►cardiovascres.org L Gao, GE Mann - Cardiovascular Research, 2009 - cardiovascres.oxfordjournals.org Oxidative stress mediated by hyperglycaemia-induced generation of reactive
oxygen species (ROS) contributes significantly to the development and
progression of diabetes and related vascular complications. NAD(P)H oxidase ... Cited by 7 - Related articles - All 6 versions
MA Potenza, F Addabbo, M Montagnani - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc Hemodynamic actions of insulin depend largely on the hormone's ability to
stimulate synthesis and release of endothelial mediators, whose balanced
activity ensures dynamic control of vascular function. Nitric oxide (NO), ... Cited by 1 - Related articles - All 3 versions
- ►angrylapdog.com SJ Peterson, DH Kim, M Li, V Positano, L … - The Journal of Lipid Research, 2009 - ASBMB We examined mechanisms by which L-4F reduces obesity and diabetes in obese (ob)
diabetic mice. We hypothesized that L-4F reduces adiposity via increased pAMPK,
pAKT, HO-1, and increased insulin receptor phosphorylation in ob mice. ... Related articles - All 8 versions
ZT Bloomgarden - Diabetes care, 2009 - Am Diabetes Assoc Gary Lewis (Toronto, Canada) discussed the effect of prolonged free fatty acid
(FFA) elevation on pancreatic β-cell function. FFAs are essential for
maintenance of basal insulin secretion, and acute FFA elevation increases ... Related articles - All 4 versions
H Imrie, A Abbas, H Viswambharan, A … - Endocrinology, 2009 - Endocrine Soc Obesity and type 2 diabetes mellitus are characterized by insulin resistance,
reduced bioavailability of the antiatherosclerotic signaling molecule nitric
oxide (NO), and accelerated atherosclerosis. IGF-I, the principal growth- ... Related articles - All 4 versions